Investment Summary

Exits Radpharm Scientific Pty.

On February 16, 2010, invested in medical products company Radpharm Scientific Pty. from Ampersand Capital Partners

Investment Highlights
  • This is transaction in the Medical Products sector.
  • This is transaction in the United States.
  • This is transaction in New Jersey.

Investment Summary

Date 2010-02-16
Target Radpharm Scientific Pty.
Sector Medical Products
Sellers(s) Ampersand Capital Partners
Deal Type Merger

Target

Radpharm Scientific Pty.

Princeton, New Jersey, United States
website
Medical imaging services for clinical trials

Search 177,534 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.


DEAL STATS #
Overall 12 of 51
Sector (Medical Products) 4 of 13
Type (Merger) 1 of 2
State (New Jersey) 1 of 5
Country (United States) 12 of 49
Year (2010) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-05 Medifacts International

Rockville, Maryland, United States

Medifacts International, Inc. is a provider of cardiac safety services for biopharmaceutical and medical device sponsors.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-15 Signature Genomic Laboratories

Spokane, Washington, United States

Signature Genomic Laboratories, LLC is a provider of microarray-based cytogenetic diagnostics with its proprietary SignatureChip and is the major in providing microarray-based chromosome analysis.

Sell -